Indian Journal of Transplantation

REVIEW ARTICLE
Year
: 2019  |  Volume : 13  |  Issue : 2  |  Page : 69--77

Renal allograft dysfunction: An update on immunological graft injury


Praveen Kumar Etta, MV Rao 
 Department of Nephrology and Renal Transplantation, Asian Institute of Nephrology and Urology, Hyderabad, Telangana, India

Correspondence Address:
Dr. Praveen Kumar Etta
Department of Nephrology and Renal Transplantation, Asian Institute of Nephrology and Urology, Hyderabad - 500 082, Telangana
India

Renal transplantation is the treatment of choice in most patients with end-stage renal disease, especially with improvement in surgical techniques and immunosuppressive regimens; however, the long-term graft survival remains to be improved. Immunological graft injury leading to rejection plays a major role in long-term graft loss. With pretransplant immunological evaluation using various crossmatch tests, identification of donor-specific antibodies, a better understanding of renal allograft pathology and its standardization with the Banff classification having regular updates led to prevention, early and accurate diagnosis of rejection and its histological differentiation. Some newer biomarkers are in pipeline may enable early and accurate identification of graft pathology noninvasively.


How to cite this article:
Etta PK, Rao M V. Renal allograft dysfunction: An update on immunological graft injury.Indian J Transplant 2019;13:69-77


How to cite this URL:
Etta PK, Rao M V. Renal allograft dysfunction: An update on immunological graft injury. Indian J Transplant [serial online] 2019 [cited 2020 Feb 26 ];13:69-77
Available from: http://www.ijtonline.in/article.asp?issn=2212-0017;year=2019;volume=13;issue=2;spage=69;epage=77;aulast=Etta;type=0